Current role
Andrew Serafin
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Harmony Biosciences Holdings, Inc. (HRMY)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Harmony Biosciences Holdings, Inc. (HRMY) | EVP, Chief Strategy Officer | $420,294 | $2,087,422 |
| 2023 | Harmony Biosciences Holdings, Inc. (HRMY) | EVP, Chief Strategy Officer | $402,195 | $647,425 |
| 2022 | Harmony Biosciences Holdings, Inc. (HRMY) | EVP, Chief Strategy Officer | $375,673 | $605,422 |
| 2021 | Harmony Biosciences Holdings, Inc. (HRMY) | EVP, Chief Strategy Officer | — | — |
| 2020 | Harmony Biosciences Holdings, Inc. (HRMY) | EVP, Chief Strategy Officer | — | — |
| 2019 | Harmony Biosciences Holdings, Inc. (HRMY) | EVP and Chief Strategy Officer | — | — |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.